Coherus BioSciences Ownership | Who Owns Coherus BioSciences?

Overview Forecast RevenueFinancials Chart Transcripts

Coherus BioSciences Ownership Summary

Coherus BioSciences is owned by 53.31% institutional investors, 6.54% insiders, and 40.16% retail investors. Blackrock is the largest institutional shareholder, holding 10.42% of CHRS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.96% of its assets in Coherus BioSciences shares.

CHRS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Coherus BioSciences	53.31%	6.54%	40.16%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	11.75M	10.42%	$20.33M
Vanguard group	11.15M	9.68%	$15.39M
Blackrock funding, inc. /de	11.08M	9.61%	$15.28M
Rubric capital management lp	5.26M	4.56%	$7.26M
Tang capital management	3.65M	3.17%	$5.04M
Kohlberg kravis roberts	3.04M	2.64%	$4.15M
Geode capital management	2.60M	2.26%	$3.59M
State street	2.18M	1.89%	$3.00M
Cm management	2.05M	1.78%	$2.83M
C worldwide group	1.93M	1.67%	$2.66M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cm management	2.05M	2.53%	$2.83M
Tejara capital	738.16K	0.67%	$1.02M
Tang capital management	3.65M	0.33%	$5.04M
Stonepine capital management	250.00K	0.28%	$345.00K
Kohlberg kravis roberts	3.04M	0.11%	$4.15M
Rubric capital management lp	5.26M	0.09%	$7.26M
Tyche wealth partners	266.77K	0.08%	$368.14K
Wealth group	52.20K	0.05%	$72.00K
C worldwide group	1.93M	0.03%	$2.66M
State of wyoming	119.27K	0.02%	$164.59K

Top Buyers

Holder	Shares	% Assets	Change
Tang capital management	3.65M	0.33%	1.30M
Jacobs levy equity management	1.00M	0.01%	1.00M
Ubs group	709.00K	0.00%	535.83K
Blackrock	11.75M	0.00%	521.98K
Norges bank	491.50K	0.00%	491.50K

Top Sellers

Holder	Shares	% Assets	Change
Temasek (private)	-	-	-5.82M
Point72 asset management	-	-	-5.28M
Rubric capital management lp	5.26M	0.09%	-5.14M
Barclays	300.19K	0.00%	-2.17M
Bank of america corp /de/	275.10K	-	-2.15M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	491.50K	0.00%	491.50K	$850.29K
Stonepine capital management	250.00K	0.28%	250.00K	$345.00K
Gsa capital partners llp	123.02K	0.01%	123.02K	$170.00K
Strs ohio	94.60K	0.00%	94.60K	$163.66K
Ieq capital	49.18K	0.00%	49.18K	$67.87K

Sold Out

Holder	Change
Eagle bay advisors	-30.00
Nelson, van denburg & campbell wealth management group	-31.00
Newbridge financial services group	-79.00
Rothschild investment	-95.00
Harbour investments	-100.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	117	-7.14%	61,758,313	-5.38%	53	1.66%	50	-18.03%	34	6.25%
Dec 31, 2024	75	-42.75%	35,423,873	-53.96%	30	0.69%	37	-35.09%	18	-47.06%
Sep 30, 2024	131	-5.07%	76,943,748	-5.87%	66	1.32%	57	-20.83%	34	-2.86%
Jun 30, 2024	137	-4.86%	81,739,887	0.11%	72	0.96%	72	20.00%	35	-35.19%
Mar 31, 2024	144	-11.11%	81,648,563	0.42%	86	1.25%	60	-25.00%	54	-3.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	3.43M	2.96%	-
Vanguard Total Stock Mkt Idx Inv	3.43M	2.96%	-
iShares Russell 2000 ETF	2.80M	2.42%	1.37K
C WorldWide Healthcare Select 1A	1.93M	1.66%	-
Vanguard Institutional Extnd Mkt Idx Tr	1.92M	1.66%	-
Vanguard Strategic Equity Inv	1.71M	1.47%	-
Vanguard Explorer Inv	1.69M	1.46%	-
Fidelity Small Cap Index	1.13M	0.97%	23.72K
AlphaCentric LifeSci Healthcare I	1.00M	0.87%	-
BlackRock Advantage Small Cap Core Instl	1.00M	0.86%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 23, 2025	Wahlstrom Mats	-	Sell	$73.88K
Nov 22, 2023	Lanfear Dennis M	President & CEO	Sell	$449.77K
Oct 15, 2021	Stilwell McDavid	Chief Financial Officer	Sell	$58.92K
Sep 28, 2021	HEALY JAMES	-	Sell	$829.81K
Sep 27, 2021	HEALY JAMES	-	Sell	$1.81M

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

CHRS Ownership FAQ

Who Owns Coherus BioSciences?

Coherus BioSciences shareholders are primarily institutional investors at 53.31%, followed by 6.54% insiders and 40.15% retail investors. The average institutional ownership in Coherus BioSciences's industry, Biotech Stocks , is 63.96%, which Coherus BioSciences falls below.

Who owns the most shares of Coherus BioSciences?

Coherus BioSciences’s largest shareholders are Blackrock (11.75M shares, 10.42%), Vanguard group (11.15M shares, 9.68%), and Blackrock funding, inc. /de (11.08M shares, 9.61%). Together, they hold 29.72% of Coherus BioSciences’s total shares outstanding.

Does Blackrock own Coherus BioSciences?

Yes, BlackRock owns 10.42% of Coherus BioSciences, totaling 11.75M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 20.33M$. In the last quarter, BlackRock increased its holdings by 521.98K shares, a 4.65% change.

Who is Coherus BioSciences’s biggest shareholder by percentage of total assets invested?

Cm management is Coherus BioSciences’s biggest shareholder by percentage of total assets invested, with 2.53% of its assets in 2.05M Coherus BioSciences shares, valued at 2.83M$.

Who is the top mutual fund holder of Coherus BioSciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Coherus BioSciences shares, with 2.96% of its total shares outstanding invested in 3.43M Coherus BioSciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools